Passage Bio Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, Nov. 19, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted an inducement award to a new employee.…